Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$25.27 - $54.9 $252,700 - $549,000
-10,000 Reduced 21.28%
37,000 $1.93 Million
Q3 2020

Nov 13, 2020

BUY
$18.49 - $27.24 $684,130 - $1.01 Million
37,000 Added 370.0%
47,000 $1.26 Million
Q2 2020

Aug 14, 2020

BUY
$8.9 - $21.84 $89,000 - $218,400
10,000 New
10,000 $195,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.54B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.